Also, Europe has their own equivalent of an IND filing. No one has mentioned seeing anything listed there either. Bottom line, if ITV-1, Clone 3 or any other mabs were in clinical trials, we would know about it bc of these required filings.
That’s why I mentioned the other day that the timelines Charles laid out in that spring 2021 live interview were not met and pretty much have all passed. Hell, I remember that day vividly as the price tanked from the .20’s to low teens within an hour right when he mentioned some of the 1-2 years out timelines. Most people invested at the time obviously were not expecting to hear those timeframes. Well we are basically two years out now and don’t appear to even have begun any clinical trials, so that’s not a pleasant thought.
The Regeneron speculation does seem like more than just a coincidence and I’d be shocked if it weren’t us, for reasons you pointed out and the fact the language was just too similar. I’d say that’s our best hope for any clinicals within the next few months.
Frustrated beyond belief here but still trying to remain hopeful. Better late than never right.
News 
Market Data 
Discover 
